MedPath

ATROPINE SULFATE

ATROPINE SULFATE INJECTION, USP 1mg/mL 1mL VIAL

Approved
Approval ID

c4c658a0-93f0-6639-e053-2a95a90abffa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 14, 2021

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATROPINE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1509
Product Classification
G
Generic Name
ATROPINE SULFATE
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateJune 14, 2021
FDA Product Classification

INGREDIENTS (4)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
ATROPINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: 03J5ZE7KA5
Classification: ACTIB
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATROPINE SULFATE - FDA Drug Approval Details